The segment dives into significant FDA and NIH announcements, including a new autism treatment (Leucovorin) and updated acetaminophen warnings. BKP praises Trump’s bold leadership in prioritizing children’s health and criticizes the media for ignoring these developments in favor of attacking Trump.
- FDA and NIH Developments:
- FDA approves Leucovorin for autism treatment, a major step not covered by mainstream media.
- NIH launches a $1 million autism research initiative with 250 teams studying root causes, focusing on environmental and genetic factors.
- FDA updates acetaminophen labels to warn pregnant women of potential neurodevelopmental risks, backed by studies from Johns Hopkins, Yale, and Harvard.
- Expert Insights:
- Dr. Marty McCary (FDA) emphasizes a historic shift in medical culture, prioritizing root causes over corporate interests.
- Dr. Fink (pediatrician) encourages parents to consult doctors and take minimal acetaminophen doses during pregnancy.
- Dr. Oz highlights the need to spread out vaccine doses to reduce potential risks to infants.
- Media Suppression:
- Networks like CNN and MSNBC ignore FDA/NIH announcements, focusing instead on Trump’s Tylenol comments and mispronunciations.
- Sanjay Gupta (CNN) dismisses Tylenol-autism links, citing “decades of evidence” without addressing new studies.
- Global Context:
- Mentions UN assembly, Macron’s two-state solution support, and rising global tensions, urging viewers to stay vigilant.

